Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study

Anissa M. Tsonas(Amsterdam UMC Location University of Amsterdam), Frederique Paulus(Amsterdam University Medical Centers), Marcus J. Schultz(University of St.Gallen), Gentle Sunder Shrestha(Tribhuvan University Teaching Hospital), Oriol Roca(Corporació Sanitària Parc Taulí), Michela Botta(Amsterdam University Medical Centers), Ary Serpa Neto(The University of Melbourne)
Pulmonology
September 15, 2022
10.1016/j.pulmoe.2022.09.003
Cited by 5

Related Papers

Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
|Nature Immunology|2016|615
Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis
|JAMA|2016|551
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
|Science|2020|415
The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline
|Intensive Care Medicine|2020|413